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1. Introduction  
1.1 Theme and scope 
In this chapter, we are studying the course (i) of cardiomyopathy diseased LVs (with 
myocardial infarcts) progressing to heart failure (HF) through LV remodelling and 
decreased LV contractility, and (ii) their recovery through surgical therapeutic interventions 
of CABG and Surgical Ventricular Restoration (SVR), by restoration of myocardial ischemic 
segments, reversal of LV remodeling and improvement in LV contractility.  
For this purpose, we first provide the methodology for detecting myocardial infarcts.  Then, 
we characterize LV remodeling of cardiomyopathy diseased LVs (with myocardial infarcts) in 
terms of reduced change in curvedness from end-diastole to end-systole.  In these LVs, there is 
also reduced contractility; so we provide an index for cardiac contractility, in terms of maximal 
rate-of-change of normalized wall stress, dσ*/dtmax, and its decrease in an infarcted LV 
progressing to heart failure.  We provide clinical studies of remodeled cardiomyopathy 
diseased LVs, in terms of reduced values of their curvedness index and contractility index.  
By way of therapeutic interventions, we have presented the hemodynamic flow simulation 
of the CABG (carried out to enhance myocardial perfusion in the region around the blocked 
coronary artery), and pointed out certain factors and sites of wall shear stresses that cause 
intimal damage of vessels and hyperplasia, as potential causes for decreased patency.  We 
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have shown that surgical ventricular restoration (SVR), in conjunction with CABG, is seen to 
benefit the ischemic-infarcted heart, by (i) restoration of cardiac remodeling index of ‘end-
diastolic to end-systolic curvedness change’, (ii) reduction of regional wall stresses, and (iii) 
augmentation of the cardiac contractility index value.  
2. Myocardial infarction: What it entails 
In Cardiology, the etiology of congestive heart failure (CHF) is coronary artery disease in 
approximately two-thirds of cases. The majority of these patients have hearts with 
myocardial infarcted segments. This infarcted myocardial wall mitigates adequate 
contraction of the wall. So, the end-result of an infarcted left ventricle (LV) is poor intra-LV 
velocity distribution and pressure-gradient distribution, causing impaired outflow from the 
LV into the aorta. 
In the infarcted myocardial segments, the myocardial infrastructure of actin and myosin 
filaments (and their cross – bridges) is disrupted, and hence there is no contraction within 
these infarcted myocardial segments. The below figure 1 illustrates a myocardial sarcomere 
segment’s bioengineering model, composed of two symmetrical myocardial structural units 
(MSUs). In these MSU(s), the contractile elements represent the actin-myosin contractile 
components of the sarcomere segment. The disruptions of these contractile elements impair 
the contractile capability of that sarcomere segment. Hence, a LV with infarcted myocardial 
segments will have diminished contractility, inadequate and improper intra-LV flow, and 
poor ejection. 
 
 
Fig. 1. Based on the conventional Hill three-element model and Huxley cross bridge theory, 
we have developed a myocardial model involving the LV myocardial mass, series-elastic 
element (CE),. In this figure we have linked the anatomical associations of these myocardial 
model elements with microscopic structure of the heart muscle. This figure illustrates the  
sarcomere element contractile model, involving: the effective mass (m) of the muscle tissue 
that is accelerated: elastic parameter k of the series element stress σSE (k = elastic modulus of 
the sarcomere), viscous damping parameter B of the stress σVE in the parallel viscous 
element VE, the generated contractile stress  σCE between myosin (thick ) and actin (thin ) 
filaments.  
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3. Detection of myocardial infarcted segments 
Now, infarcted myocardial segments can be detected as highly reflectile echo zones (HREZs) 
in 2-dimensional B-scan echocardiograms. In this context, we have shown how infarcted 
myocardial segments can be detected (in shape and size), by echo-texture analysis, as highly 
reflectile echo zones or HREZs.  Each myocardial tissue component of the heart generates a 
grey scale pattern or texture related to the tissue density and fibrous content. In diseased 
states (such as myocardial ischemia, myocardial fibrosis, and infiltrative diseases), changes 
in myocardial tissue density have been recognised by employing echo intensity and mean 
grey level of pixel as the basis for recognition of such myocardial disorders. It is found that 
hyper-reflectile echoes (HREs) correlated well with diseased cardiac muscle, and that 
myocardial tissue containing HREs corresponded with foci of sub-endorcardial necrosis and 
even calcification.  
In our study [1], in order to determine highly reflectile echo zones (HREZs), 
echocardiograms were recorded, and each image was made up of 256 x 256 pixels, with each 
pixel having a resolution of 0-256 grey scales. The echocardiographic images were digitised 
into 256 grey scales. Then, echo intensity levels from normal infants were used to delineate 
the range of echo intensities for normal tissues. The upper bound of the echo intensity was 
set to 100 per cent in each normal infant, and the intensities from the rest of the image were 
referenced to this level. Normally, pericardium had the highest intensity level. It was found 
that the upper-bound of the echo intensity value for healthy tissue (expressed as a 
percentage of the pericardial echo intensity value) was 54.2. 
 
 
Table 1. Echo intensity values for various anatomic regions of diseased pediatric hearts 
(based on long axis view). The numbers in the four rows represent Mean (M), Standard 
Deviation (SD), Number of Pixels (N), Percentage of Posterior Pericardial Intensity (P). This 
figure is adopted from Ref [1]. 
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For patients whose echo-texture analysis showed presence of HREs, it was found that the 
echocardiographic intensities of the HREs from these patients intensities were distinctly 
higher than the echo intensity range of normal tissue (as depicted in Table 1). 
Myocardial tissue pixels having echo-intensity values greater than 200 are generally noted to 
be infarcted.  This region’s echo-intensity values can remain unaffected by administration of a 
myocardial perfusing agent.  This infarcted sub-region is seen to be surrounded by an ischemic 
sub-region whose pixels are noted to have echo intensity values between 100 and 200. This 
region’s echo-intensity can be reduced by the administration of a myocardial perfusing agent.  
The surrounding healthy tissue has echo intensity less than 100.  Figure 2(a) depicts an echo 
image of an infant with visible scars regions 1 and 2, while figure 2(b) depicts printouts of the 
echo intensities from these two regions, wherein the infarcted segments are depicted in dark 
colour and the surrounding ischemic segments are depicted in a lighter shade. 
 
 
Fig. 2. (a) Long axis view of a pediatric patient’s heart showing HRE regions 1 and 2 and a 
healthy region 3 [1]. 
 
 
Fig. 2. (b) Pixel values correcponding to highly reflectile echo region 1. The central region 
having echo-intensity values greater than 200 is infarcted, while its immediately 
surrounding region shown in lighter shade is ischemic.  
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In this way, in each highly reflectile echo zone (HREZ) made up of , say, N number of pixels, 
we can determine the number (I) of infarcted pixels. The ratio I/N represents the infarcted 
potion of that HREZ myocardial segment. The total number of all the infarcted pixels in all 
the HREZs provides an indication of the amount of infarcted myocardium of the heart or of 
the LV. 
4. Cardiac remodeling following myocardial infarction and progression to 
heart failure 
Myocardial infarction (MI) reduces the amount of ventricular contractile myocardium, 
which in turn reduces the left ventricular (LV) contractile capacity for pumping out 
adequate cardiac output (CO). As MI extends, it progresses into heart failure (HF).  A 
manifestation of MI and its decreased contractile capacity is the inability of the LV to retain 
its compact systolic curved shape. In other words, in HF resulting from MI, the left ventricle 
undergoes remodeling and its curvedness index decreases. As MI progresses into HF, LV 
size increases, LV function deteriorates, and symptoms of HF become evident.  Thus, 
cardiac remodeling (expressed in terms of regional curvedness of the LV) constitutes a 
measure of the progression of HF after MI, and interventions causing some reversal of this 
LV remodeling process have been shown to improve mortality in patients with HF. 
Therefore, reversal of LV remodeling (through medical or surgical treatment) has been 
emerging as a therapeutic target in HF of all etiologies. The challenge is to develop specific 
measures of LV remodeling that can be incorporated into the clinical management pathway. 
For patients with HF after MI, the LV shape is more spherical in terms of the global 
sphericity index. However, focus on global sphericity index may be misleading, since the 
simple plane ratio reflects a linear alteration in the two axes of the LV chamber. Hence, 
regional curvedness index, determined from 3D magnetic resonance imaging (MRI)-based 
LV model, is proposed as a measure of LV shape. The curvedness value describes the 
magnitude of the curvature at a surface point, i.e., a measure of degree of curvature a point; 
the regional curvedness describes the curvedness of the segment of the LV.  In MI patients, 
the regional curvedness index value does not increase significantly from end-diastole to 
end-systole (due to decreased LV contractile capacity), as in the case of normal patients.   
In the case of patients with HF following MI, the LV cannot generate adequate contractile 
force, as explained earlier in section 1. As a result, the overall LV contractility index of 
maximal rate-of-change of normalized systolic wall stress dσ*/dtmax is decreased, and the 
LV ejection force is also diminished.  Now, LV regional wall stress is proportional to the 
wall surface radius-of-curvature and inversely proportional to the wall thickness.  Hence, 
for patients with HF after MI, the inability of the remaining viable myocardium to 
compensate for the increased wall stress associated with LV dilatation and thinning is a 
trigger for LV enlargement.  
4.1 Remodeling quantification in terms of local curvedness indices and regional 
curvedness index 
4.1.1 Overall approach 
The remodeling is characterized in terms of the Regional Curvedness index of the 16 segments 
of the LV endocardial surface. The method entails generation of the LV endocardial shape 
and its compartmentalization into 16 segments or regions (as explained later on). Each 
segment is discretized into triangular meshes, so that a point on the endocardial surface is a 
vertex of a triangular mesh. At each vertex point, we determine the Local Curvedness index 
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[2], by employing its surrounding neighboring vertices in the form of n-rings around the 
local point. To ensure accurate curvedness computation without over smoothing, the 
optimal number of n-rings is determined to be 5. Then, for each segment, we determine the 
Regional Curvedness index, as the mean of the Local Curvedness indices in the segment. 
The values of Regional Curvedness are determined for normal and MI patients, at end-
diastolic and end-systolic instants. For normal patients, the Regional Curvedness index 
changes significantly from diastole to systole, as given by the Diastole-to-Systole Change in 
Curvedness (%∆C) [2] 
 % 100ED ES
ED
C C
C
C
−∆ = ×  (1) 
wherein CED and CES are end-diastolic and end-systolic curvedness, defined later on. The 
mean alteration in regional curvedness index value of %∆C is determined for all the 
segments, for normal subjects and MI patients (and logged in Table 3).  It can be seen that 
for MI patients, the regional curvedness index or (%∆C) does not change significantly from 
end-diastole to end-systole, in comparison with normal subjects. 
4.1.2 Clinical application methodology 
Our study involved 10 normal subjects and 11 patients after myocardial infarction (MI). The 
hemodynamic and volumetric parameters of the subjects are summarized in Table 2. 
Human Subjects and MRI Scans: The study to characterize regional curvedness index or (%∆C) 
involved ten normal subjects and 11 patients after myocardial infarction [2]. All subjects 
underwent diagnostic MRI scans. For each subject, short-axis MRI images were taken along 
the plane which passes through the mitral and aortic valves of the heart at an interval of 8mm 
thickness. Each image has a spatial resolution of 1.5mm, acquired in a single breath hold, with 
25 temporal phases per heart cycle. Of these images, the set of images corresponding to the 
cardiac cycle at end-diastole and end-systole are then used for the study. 
LV Endocardial Surface Reconstruction and Segmentation: The MRI images were processed, 
by using a semi-automatic technique that is included in the CMRtools suite (Cardiovascular 
Solution, UK). The contours demarcating the myocardium and the LV chamber were 
defined by means of B-spline curves. The endocardial surface of the LV was reconstructed 
by joining the series of contours to form a triangle mesh.  In order to facilitate quantification 
of the LV segmental regional curvedness, the endocardial surface was partitioned into 16 
segments; the method of segmentation of the LV endocardial surface is provided in our 
paper [2]. 
Left Ventricular Shape Analysis: To quantify LV remodeling, we first define a measure known 
as the Local Curvedness index [2]. This is essentially a shape descriptor used to quantify how 
curved the surface is in the vicinity of a vertex on the LV endocardial surface. This is done 
by using the 3-d mesh of the LV endocardial surface as an input. Each vertex of the mesh is 
processed by fitting a quadric surface over a local region around the vertex as described in 
our paper [2]. The extent of this local region is determined by the n-ring parameter. Next, 
the Local Curvedness index of each vertex can be calculated from the coefficients of the fitted 
quadric surface by [2]: 
 
( )2 2 22 2
1 2
2
2 41
2
B A ac b
C
AA
κ κ + −+
= =  (2) 
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such that  
2 2 1A d e= + +  
2 2B a ae c cd bde= + + + +  
where a, b, c, d and e are the coefficients of the fitted quadric surface at the vertex. 
In order to derive the Regional Curvedness, the endocardial surface is partitioned into 16 
segments (Fig 3). The Regional Curvedness for the each segment is the mean of the Local 
Curvedness indices in the segment. The flowchart of the overall workflow for the regional LV 
shape analysis is shown in Fig. 4. 
4.1.3 Clinical studies results 
In our clinical studies, it was found that (1) MI patients exhibit decreased curvedness and 
%ΔC, (2) MI patients exhibit increased variation of curvedness and variation of %ΔC, and (3) 
LV ejection fraction is positively correlated with curvedness and %ΔC, and inversely 
correlated with variation of %ΔC. 
The Diastole-to-Systole Change in Curvedness (%ΔC), as defined by equation (1), is a measure 
of regional deformity due to contraction.  Positive values of %ΔC indicate regions of 
increasing inward concavity of the LV wall during systole, while negative values of %ΔC 
indicate wall regions of decreasing inward concavity. The %ΔC measure can be employed to 
relate the regional differences in hypokinesis due to myocardial infarction. 
Variation of curvedness: The extent of LV surface inhomogeneity is characterized by a 
coefficient of variation of curvedness at end-diastole (CV_CED) and end-systole (CV_CES): 
 
( )
( )_
C
CV C
C
σ
µ
=  (3) 
where σ(C) is the standard deviation of the regional curvedness and µ(C) is the mean of the 
regional curvedness of the segments of the LV mesh. 
To evaluate the extent of functional non-uniformity of LV regions, the index CV_DC was 
determined as [2]: 
 
_ _
_ 100
_
ED ES
ED
CV C CV C
CV C
CV C
−∆ = ×  (4) 
In general, the larger the values of CV_CED and CV_CES, the more inhomogeneous the LV 
endocardial surface appears. Hence, the larger the value of index CV_∆C, the more 
functionally non-uniform are the LV shape changes due to LV contraction.   
Curvedness, Variation of curvedness and Diastole-to-systole change %ΔC in MI patients compared 
to Normal subjects:  The hemodynamic and volumetric parameters of the subjects are 
summarized in Table 2. For patients after MI, the LV ejection fraction was significantly 
lower than that in the control subjects. In addition, their LV end-diastolic and end-systolic 
indexed volumes were greater than those in the control subjects.  
The values of regional curvedness from apex to base in MI patients and normal subjects are 
given in Table 3 and Fig. 5, to highlight the regional variations of the LV curvature. In the 
normal group, there was a significant increase in the curvedness at the apex from diastole to 
systole. However, in MI patients, there was no significant difference in curvedness in all 
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segments. Significant differences in end-diastolic curvedness CED and end-systolic curvedness 
CES were noted between MI and normal groups. Among the 16 segments of the LV, the 
variation coefficient of CES (CV_CES) was significantly lower in MI patients than in the normal 
group (18±4% in MI vs 31±8% in normal, p<0.0001), indicating fair homogeneity of LV shape 
in MI at end-systole. Correspondingly, the diastole-to-systole change in curvedness (%ΔC) was 
significantly lower, and the variation of %ΔC was higher in MI patients compared to normal 
group, indicating ventricular functional non-uniformity due to the pathologic state.  
 
 Control (n=10) MI (n=11) p value 
Age (years) 41 ± 16 60 ± 6 0.003 
Weight (kg) 67 ± 15 65 ± 14 0.30
Height (cm) 169 ± 8 165 ± 10 0.86
Diastolic pressure (mmHg) 73 ± 12 74 ± 18 0.79
Systolic pressure (mmHg) 122 ± 17 116 ± 20 0.50
HR (beats/min) 70 ± 9 84 ± 13 0.012 
CI (L/min/m2) 3.3 ± 0.4 2.2 ± 0.5 <0.001 
EDVI (ml/m2) 73 ± 10 148 ± 40 <0.001 
ESVI (ml/m2) 26 ± 6 122 ± 38 <0.001 
EF (%) 65 ± 5 18 ± 5 <0.001 
Sphericity index 0.52 ± 0.06 0.62 ± 0.08 0.01
LV mass index 56 ± 12 83 ± 13 0.004 
Table 2. Characteristics of Normal Control and Patients after MI, involved in the study. 
 
 Controls (n=10) MI (n=11) 
Segment CED(x10-2 
mm-1) 
CES(x10-2 
mm-1) 
∆C 
(%) 
CED(x10-2 
mm-1) 
CES(x10-2 
mm-1) 
∆C 
(%) 
1. Basal anterior 4.1 ± 0.8 5.6 ± 0.7 38 ± 22 3.4 ± 0.5* 3.7 ± 0.5ξ 7 ± 17# 
2. Basal anterior septal 3.4 ± 0.6 5.3 ± 1.1 57 ± 30 3.7 ± 1.0 3.7 ± 0.9* 4 ± 26ξ 
3. Basal inferior septal 3.1 ± 0.5 4.8 ± 0.6 61 ± 25 3.6 ± 0.9 4.0 ± 1.0* 12 ± 23ξ 
4. Basal inferior 4.0 ± 0.5 5.8 ± 1.0 45 ± 27 3.7 ± 1.0 4.1 ± 1.0* 13 ± 21* 
5. Basal inferior lateral 3.5 ± 0.5 5.3 ± 0.9 50 ± 22 3.0 ± 0.6* 3.3 ± 0.9ξ 13 ± 25* 
6. Basal anterior lateral  3.6 ± 0.8 5.0 ± 0.7 46 ± 26 3.1 ± 0.8 3.2 ± 0.8ξ 8 ± 24* 
7. Middle anterior 3.9 ± 0.5 6.0 ± 0.1 56 ± 20 3.4 ± 0.2* 3.6 ± 0.3ξ 6 ± 12ξ 
8. Middle anterior septal 3.9 ± 0.4 0.6 ± 1.4 55 ± 26 3.3 ± 0.6* 3.4 ± 0.4ξ 5 ± 17ξ 
9. Middle inferior septal 3.6 ± 0.6 5.2 ± 1.1 44 ± 18 3.5 ± 0.7 3.4 ± 0.5ξ 1 ± 16ξ 
10. Middle inferior 4.1 ± 0.5 6.0 ± 1.2 51 ± 31 3.8 ± 0.7 4.0 ± 0.7ξ 7 ± 17* 
11. Middle inferior lateral 3.6 ± 0.3 5.5 ± 0.8 52 ± 25 3.1 ± 0.6* 3.4 ± 0.6ξ 10 ± 14ξ 
12. Middle anterior lateral  3.2 ± 0.3 4.7 ± 0.9 45 ± 19 2.9 ± 0.5 3.0 ± 0.3ξ 4 ± 14ξ 
13. Apical anterior 4.8 ± 1.0 9.3 ± 2.0 96 ± 33 3.8 ± 0.7* 4.1 ± 1.0ξ 6 ± 15ξ 
14. Apical septal 4.9 ± 0.6 9.0 ± 1.9 83 ± 34 4.4 ± 0.7 4.6 ± 0.9ξ 4 ± 14ξ 
15. Apical inferior 5.7 ± 0.9 11 ± 2.8 90 ± 44 4.7 ± 1.0* 4.9 ± 1.0ξ 5 ± 14ξ 
16. Apical lateral 4.4 ± 0.7 8.8 ± 2.2 103 ± 65 3.8 ± 0.4 4.0 ± 0.7ξ 2 ± 12ξ 
Mean 4.0 ± 0.4 6.5 ± 1.0 61 ± 18 3.6 ± 0.5* 3.8 ± 0.5ξ 7 ± 9ξ 
Coefficient of variation (%) 21 ± 5 31 ± 8 51 ± 14 19 ± 5 18 ± 4ξ 392 ± 501* 
*, p<0.05; #, p<0.01; ξ, p<0.001 
Table 3. Left ventricular Regional curvedness, Diastole-to-systole change in curvedness 
(%ΔC), Variation of curvedness and %ΔC in MI compared to normal state, as defined by 
equation (1). This table is related to our work in Ref [2]. 
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Fig. 3. Partitioning of LV mesh into 16 segments; this figure is based on our work in Ref. [2]. 
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Fig. 4. Flowchart of the overall workflow for the regional LV shape analysis; this figure is 
based on our work in Ref. [2]. 
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Fig. 5. Comparison of regional curvedness (5-ring selection) in normal subjects and patients 
after myocardial infarction; this figure is based on our work in Ref. [2]. 
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5. Employment of cardiac contractility Index dσ*/dtmax to demonstrate (i) its 
excellent correlation with traditional contractility index dP/dtmax, in patients 
with varying ejection fractions, and (ii) its capacity to diagnose Heart failure 
with normal ejection fraction (HFNEF, or diastolic heart failure) and with 
reduced ejection fraction (HFREF, or systolic heart failure)  
5.1 Cardiac contractility expressed in terms of maximum rate of change of pressure-
normalized LV wall stress, dσ*/dtmax 
Left Ventricular (LV) contractility can be termed as the capacity of the LV to develop intra-
myocardial stress, and thereby intra-cavitary pressure, to eject blood volume as rapidly as 
possible. It is hence rational and appropriate to formulate a LV contractility index on the 
basis of LV wall stress.  The traditional dP/dtmax is based on left ventricular intra-cavitary 
pressure which is generated by an active myocardial stress. Hence, analogous to dP/dtmax, 
which is based on LV intra-cavitary pressure, we have formulated a novel LV contractility 
index based on LV wall stress, namely the maximum rate of change during systole of LV 
wall stress normalized to LV intra-cavitary pressure, d(σ/P)/dtmax or dσ*/dtmax , where 
σ* = σ /P [3]. 
Model Analysis and Index Formulation: For mathematically simplicity, we have approximated 
the LV as a thick-wall spherical shell consisting of incompressible, homogeneous, isotropic, 
elastic material. The maximum circumferential wall stress ( θσ ) can be expressed at the 
endocardium, as: 
 ( )
3 3
3 3
/ 1 / 2
1 /
i e
i
i e
r r
r P
r r
θσ
⎡ ⎤+
= ⎢ ⎥
−⎢ ⎥⎣ ⎦  (5)  
where ri and re are the inner and outer radii, P is LV intracavitary pressure.  
By normalizing wall stress to LV intra-cavitary pressure (P), we obtain: 
 ( )
3 3
3 3 3
* 1
2
i e
i
e i i
r r
r
P r r r
θσσ
⎛ ⎞
= = +⎜ ⎟⎜ ⎟
− ⎝ ⎠   (6) 
Since the maximum wall stress occurs at the inner endocardial wall, we have: 
 ( ) ( )( )
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where P is LV intra-cavitary pressure; θσ  is the wall stress; V (=
34 / 3irpi ) denotes LV 
volume; Vm (= ( )3 34 / 3e ir rpi − ) denotes LV myocardial volume; ri and re are the inner and 
outer radii of the LV, respectively.  Differentiating equation (7) with respect to time, we get: 
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/ 3
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θσσ
⎛ ⎞
= = ⎜ ⎟⎝ ⎠   (8) 
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It can be thus noted that in contrast to the indices of dP/dtmax, Ees and Ea,max, our dσ*/dtmax 
index can be determined solely from non-invasive assessment of LV geometry and flow. 
Normalizing LV wall stress to LV pressure obviates the need for invasive LV pressure 
measurement.  
Our LV contractility formulation has been based on the premise that LV wall stress  
(due to LV myocardial sarcomere contraction) is responsible for the development  
of LV pressure. Hence, it is more rational to base LV contractile function on  
LV wall stress per pressure. Hence, analogus to dP/dtmax, this LV contractility index  
is formulated as the maximal rate of pressure-normalized wall stress (as given  
by the above equation 8), to represent the maximal flow rate out of the ventricle  
(dV/dt) normalized to myocardial volume (Vm).  This is somewhat in keeping with cardiac 
output or maximal volume change having been used as a measure of myocardial 
contractility in rats or human, provided that the influence of afterload is taken into 
account.  
5.2 Medical application to subjects with varying ejection fractions, to demonstrate 
excellent correlation of dσ*/dtmax with dP/dtmax 
We have validated dσ*/dtmax against dP/dtmax and Ea,max in 30 subjects with disparate 
ventricular function in Figure 6, and demonstrated the index’s load independence, albeit 
under conditions of limited preload and after load manipulations [3].   
For this study, thirty volunteers [mean 58.1 (range 48–77) yr of age, 13:2 male-to-female 
ratio] with diverse cardiac conditions were recruited.  From their LV pressure-volume 
data, LVEF and dP/dtmax were computed directly from these traces. Active elastance Ea at 
various times was also computed from the pressure-volume loops, from the data in Table 
4, based on our earlier work on Ea definition and determination [4].  Ea,max was 
extrapolated from the peak of the Ea-time curve [4].  The single-beat estimation of end-
systolic elastance Ees (SB) was determined, using bilinearly approximated time-varying 
elastance [5].  
The patients were divided into three groups on the basis of tertiles of LVEF, with 10 
individuals in each group, as shown in Table 5.  Intergroup comparisons show significant 
differences between  the mean values of dP/dtmax, Ea,max, Ees(SB), and dσ*/dtmax in those in 
the highest tertile compared with those in lowest and middle tertiles. There is agreement 
with regard to the index dσ*/dtmax with dP/dtmax, Ea,max, and Ees(SB)  across the three tertiles 
of ascending LVEF values, with statistically significant differences in LV contractility 
indexes among the three groups. Values of dP/dtmax, Ees(SB), and dσ*/dtmax were 
statistically significantly lower in patients in the lowest and middle tertiles had than those 
in the highest tertile. 
Figure 6 summarizes the correlation between dσ*/dtmax, dP/dtmax, and Ea,max, as well as 
Ees(SB). Linear regression analysis revealed good correlation between dσ*/dtmax and 
dP/dtmax, Ea,max, and Ees(SB), with significant correlation coefficients in each case: 
dσ*/dtmax=0.0075dP/dtmax- 4.70 (r = 0.88, P < 0.01), dσ*/dtmax=1.20Ea,max + 1.40 (r = 0.89, 
P<0.01), and dσ*/dtmax= 1.60Ees(SB) + 1.20 (r = 0.88, P < 0.01).  In contrast, the correlation 
between dσ*/dtmaxand LVEF is less strong (r = 0.71), as is the correlation between Ees (SB) 
and LVEF (r = 0.78), underscoring the lack of specificity of LVEF as an index of 
myocardial contractility. 
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Frame No. (i) t, s P, mmHg V, ml Ea, mmHg/ml 
Isovolumic contraction
1 0 18 136.7 0 
2 0.02 22 135.7 0.0295 
3 0.04 32 134.6 0.1038 
4 0.06 52 133.5 0.2536 
5 0.08 80 132.5 0.4636 
Isovolumic relaxation
18 0.34 74 85.0 0.0590 
19 0.36 50 85.5 0.1778 
20 0.38 30 86.4 0.3127 
21 0.40 17 90.6 0.4636 
 
Table 4. Active Elastance Ea computed at discrete time points during isovolumic contraction and 
relaxation in a sample subject: i, time instant in the cardiac cycle (frame number from end-
diastole); t, time from start of isovolumic contraction; P, measured left ventricular 
intracavitary pressure; V, measured left ventricular intracavitary volume; Ea,i, calculated 
active elastance at instant i. This table is related to our work in Ref [4]. 
 
 
 
 
 
 
 Lowest tertile Middle tertile Highest tertile 
Ejection fraction 0.38 ± 0.12* 0.49 ± 0.13* 0.63 ± 0.05 
Age,yr  58.30 ± 8.86 56.10 ± 6.15 59.90 ± 6.17 
Heart rate,beats/min 71.18 ± 10.72 71.77 ± 10.68 71.46 ± 9.09 
dP/dtmax,mmHg/s 960 ± 115* 1,121 ± 113* 1,360 ±  97 
Ea,max, mmHg/ml 0.95 ± 0.32* 1.85 ± 0.59* 3.61 ± 0.62 
Ees(SB),mmHg/ml 0.72 ± 0.26* 1.51 ± 0.20* 2.81 ± 0.51 
dσ*/dtmax,s-1     2.30 ± 0.58* 3.60 ± 1.06* 5.64 ± 1.13 
 
Table 5.  LV contractility indexes classified into tertiles of LVEF: Left ventricular contractility 
indices classified into tertiles of left ventricular ejection fraction.  Values are expressed as 
mean ± standard deviation. Asterisks denote statistically significant difference (p<0.05) 
when compared with corresponding values in the highest tertile of left ventricular ejection 
fraction. dP/dtmax, peak first time-derivative of the ventricular pressure; Ea,max, maximum left 
ventricular elastance; Ees(SB), single-beat LV end-systolic elastance; dσ*/dtmax,left ventricular 
contractility index. This table is related to our work in Ref [3]. 
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Fig. 6. Linear regression analysis demonstrates good correlation between dσ*/dtmax and 
dP/dtmax : [dσ*/dtmax = 0.0075dP/dtmax-4.70, r=0.88; top figure], between dσ*/dtmax and Ea,max 
[dσ*/dtmax  = 1.20Ea,max+1.40, r=0.89; middle figure], and between dσ*/dtmax and Ees(SB) 
[dσ*/dtmax = 1.60Ees(SB)+1.20, r=0.88; bottom figure]. This figure is based on our work in Ref [3]. 
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5.3 Use of cardiac contractility index dσ*/dtmax to diagnose heart failure with normal 
ejection fraction (HFNEF) and with reduced ejection fraction (HFREF)  
In another study [6], we assessed the capacity of dσ*/dtmax to diagnose heart failure in 
patients with normal ejection fraction (HFNEF) and with reduced ejection fraction (HFREF).  
5.3.1 Introduction 
Heart failure (HF) is a major health care burden: it is the leading cause of hospitalization in 
persons older than 65 years, and confers an annual mortality of 10%. HF can occur with 
either normal or reduced LV ejection fraction (EF), depending on different degrees of 
ventricular remodeling.  Both heart failure with normal ejection fraction (HFNEF) and heart 
failure with reduced ejection fraction (HFREF), also commonly known as diastolic and 
systolic heart failure respectively, have equally poor prognosis [7]. Medical therapy targets 
to reduce load, by using vasodilators and/or to alter contractile strength using inotropic 
agents. Alternatively, some therapies target to affect cardiac remodeling, such as passive 
cardiac support devices, surgical restoration of LV shape (i.e. the Dor procedure), and stem 
cells therapies.     
Assessment of left ventricular (LV) contractility is important for HF management and 
evaluation of the heart’s response to medical and surgical therapies. Although approaches 
based on pressure-volume analysis, stress-strain analysis, and dP/dtmax-EDV relations [8]can 
provide assessments of contractile function, these relations generally require invasive data 
measured at several chamber loads and thus are difficult to apply in routine or long-term 
clinical studies. This is an important limitation, because heart failure often requires 
longitudinal evaluation. The ideal measure of contractility should have the following 
characteristics: sensitivity to inotropic changes, independence from loading conditions as 
well as heart size and mass, ease of application, and proven usefulness in the clinical setting. 
LV ejection fraction (EF) is the index overwhelmingly used to assess cardiac function in both 
clinical and experimental studies, despite the fact that it is highly dependent upon preload 
and afterload. Based on the National Heart Lung and Blood Institute’s Framingham Heart 
Study, an LVEF50% as cut-off for the presence of normal LVEF has been used in the present 
study [9]. 
Usefulness of dσ*/dtmax as Contractility Index: During LV systole, LV wall stress is 
generated intrinsically by sarcomere contraction and results in the development of extrinsic 
LV pressure. We have shown earlier that our novel LV contractility index, dσ*/dtmax 
(maximal change rate of pressure-normalized wall stress) correlates well with LV dP/dtmax 
[3]. We have proposed and validated a new LV contractility index, dσ*/dtmax ,based on the 
maximal rate of development of LV wall stress with respect to LV pressure. From the right-
hand side of equation (8), this index is also seen to represent the maximal flow rate from the 
ventricle (cardiac output) normalized to myocardial volume (or mass).  
This index is easily measured non-invasively (i.e. from echocardiography or magnetic 
resonance imaging), is sensitive to LV inotropic changes, and has been demonstrated by us 
to be preload and afterload independent [3]. Importantly, it is measured at a single steady-
state condition, as opposed to the multiple variably loaded cardiac cycles required for many 
of the other indices. Thus dσ*/dtmaxhas several qualities that make it a useful LV contractility 
index.  This study [6] has constituted an important step toward establishing the clinical 
utility of dσ*/dtmax as a tool for diagnosis of HF (both HFNEF and HFREF) as well as for 
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follow-up surveillance of LV function. Hence we see a great potential for application of this 
novel index to evaluate heart function in diverse heart conditions.  
5.3.2 Clinical methodology 
Patients referred to our echocardiography service with symptoms and signs of heart 
failure underwent echocardiography and electrocardiography (ECG). Patients with atrial 
fibrillation, more than mild mitral or aortic valvular regurgitation, and unsatisfactory 
echocardiographic images were excluded. Clinical signs of heart failure were defined as 
presence of at least one of the following: raised jugular venous pressure, peripheral 
pedema, hepatomegaly, basal inspiratory crepitation or gallop rhythm. Patients with 
LVEF ≥ 50% and LVEF < 50% on echocardiography were classified into HFNEF and 
HFREF, respectively.  
Echocardiography Study: With the subject in the left lateral decubitus position, 2D 
examinations, M-mode measurements and Doppler recordings were performed from the 
standard left parasternal long- and short-axis as well as the apical four chamber views with 
simultaneous ECG. The LVEF was assessed by using a 2-dimensional method by an 
experienced observer; normal LVEF was defined as greater or equal to 50%. Mitral flow 
velocities were obtained from the apical 4-chamber view using pulsed wave Doppler 
technique with the sample volume at the tips of the corresponding valve leaflets. LV 
outflow tract velocity was obtained from apical 5-chamber view, using pulsed wave 
Doppler technique with the sample volume at the aortic valve level.  
The measurements included peak E (peak early trans-mitral filling velocity during early 
diastole) and A (peak trans-mitral atrial filling velocity during late diastole); wave velocities 
(cm/s) were measured and E/A ratio was calculated. The E wave deceleration time (DT) 
was also calculated as the time elapsed between peak E velocity and the point where the 
extrapolation of the deceleration slope of E velocity crosses the zero baseline measured in 
milliseconds. LVOT maximal velocity Vpeak was measured, and LV mass was calculated by 
using ASE methods [10, 11]. Myocardial tissue Doppler (TDI) velocities were also estimated 
at the atrioventricular ring, septal positions, in the apical 4 chamber view. All measurements 
were averaged over two or three cardiac cycle.     
Calculation of dσ*/dtmax from Echocardiography: The contractility index was computed by the 
above equation (8).  M-mode echocardiographic measurements of the LV were obtained, 
and LV mass calculated using standardized methodology [10, 11]. Myocardial volume was 
calculated by dividing LV mass with myocardial density (assumed to be 1.05 g/ml). 
Furthermore, two-dimensional apical four- and two-chamber views of the LV were 
acquired, and end-diastolic and –systolic endocardial contours were manually outlined. The 
corresponding LVEDV were then automatically determined using biplane Simpson’s 
method.   
From Pulse-wave echo-Doppler interrogation of the LV outflow tract (LVOT), we calculated 
(in the absence of significant mitral regurgitation or aortic valve dysfunction) the maximal 
LV volume rate (dV/dtmax) during ejection: dV/dtmax=Vpeak*AVA, where Vpeak is the peak 
velocity sampled at the LVOT and AVA is the aortic valve area (= πD2/4, where D is the 
LVOT diameter measured in the two-dimensional parasternal long-axis image of the heart), 
as shown in Figure 7.  Upon substituting values of myocardial volume and dV/dtmax into 
equation (8), we determined the value of dσ*/dtmax . 
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(a)                                                                                  (b) 
Fig. 7. Echocardiographic measurement on (a) peak velocity Vpeak sampled at the LVOT and 
(b) LVOT diameter D measured in the two-dimensional parasternal long-axis image of the 
heart. This figure is adopted from Ref. [6]. 
Clinical Studies: The study involved 26 age- and sex-matched subjects in each of the groups 
of normal controls, HFNEF and HFREF. The characteristics of 78 subjects are shown in Table 
6. It summarizes the subjects’ age, BSA, LVEF, peak E, peak A, E/A ratio, DT, heart rate 
(HR), septal E/E’, lateral E/E’ and our index dσ*/dtmax. Mean dσ*/dtmax was 3.91 s-1 (95%CI, 
3.56-4.26 s-1) in control subjects; it was reduced in heart failure, HFNEF, to 2.90 s-1 (95%CI, 
2.56-3.24 s-1); and in HFREF, to 1.84 s-1 (95%CI, 1.60-2.07 s-1). There exists no substantially 
difference between the average values of LVEF, peak E, peak A, E/A ratio, DT, heart rate 
(HR), septal E/E’, and lateral E/E’ in HENEF compared to normal controls, except for 
dσ*/dtmax (2.90 ± 0.84 vs. 3.91 ± 0.87, p<0.001). However, there exists significant difference 
between the average values of LVEF, peak E, peak A, E/A ratio, DT, septal E/E’, lateral 
E/E’ and dσ*/dtmax in HEREF compared to HFNEF. 
Discussion on the Usefulness of dσ*/dtmax: During LV systole, LV wall stress is generated 
intrinsically by sarcomere contraction and results in the development of extrinsic LV 
pressure. LV wall stress is dependent on wall thickness, LV geometry and chamber pressure 
and sarcomere contraction. Hence, it is rational to quantify the LV wall stress as an intrinsic 
measure of myocardial contractility. We have proposed and validated a new LV contractility 
index, dσ*/dtmax,based on the maximal rate of development of LV wall stress with respect to 
LV pressure. From the right-hand side of equation (8),this index is also seen to represent the 
maximal flow rate from the ventricle (cardiac output) normalized to myocardial volume (or 
mass).  
Assessment of heart failure with normal ejection fraction (HFNEF) and reduced ejection 
fraction (HFREF): Heart failure may be viewed as a progressive disorder that is initiated 
after an “index event” with a resultant loss of functioning cardiac myocytes, thereby 
preventing the heart from contracting normally. HF can occur with either normal or reduced 
LV ejection fraction (LVEF), depending on different degree of ventricular remodeling. 
Perhaps 50% of patients with heart failure have a normal or minimally impaired LVEF 
(HFNEF) [12, 13].  
Although mechanisms for HFNEF remain incompletely understood, diastolic dysfunction is 
said to play a dominant role: impaired relaxation, increased passive stiffness, raised end-
Vpeak
D
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diastolic pressure (EDP) [14]. The diagnostic standard for HFNEF is cardiac catheterization, 
which demonstrates increased EDP. However, a more practical noninvasive alternative is 
echocardiography. Our study has shown that E/A ratio (1.26 ± 0.90 vs. 0.96 ± 0.38, p<0.05) 
and DT (157 ± 41 ms vs. 214 ± 47 ms, p<0.05) are significantly different between HFREF and 
normal controls, and not so between HFNEF and normal controls (Table 6).  
Our contractility index, of change rate of normalized wall stress index dσ*/dtmax, is 
dependent on lumen and wall volume of LV chamber and represents an integrated 
assessment of LV systolic performance [3], based on our findings relating dσ*/dtmax with 
HFNEF and HFREF [6]. In this study, as shown in Table 7, we find that there exists 
significant difference in dV/dtmax between HFREF and HFNEF (233±48 ml/s vs. 355±65 ml/s, 
p<0.05), while there exists no difference between HFNEF and normal controls (355±65 ml/s 
vs. 353±80 ml/s, NS). Similarly, there exists significant difference in LV mass between 
normal controls and HFNEF (147±41 g vs. 202±47 g, p<0.05), while there is no difference 
between HFREF and HFNEF (213±60 g vs. 202±47 g, NS).  
Our dσ*/dtmax index, using dV/dtmax normalized with LV mass, can clearly differentiate 
HFREF, HFNEF and normal controls (p<0.05) (Table 7). The average value of dσ*/dtmax 
decreases in HFNEF and HFREF, in relation to normal controls. The mean value of dσ*/dtmax 
was found to be 3.91 s-1 (95%CI, 3.56-4.26 s-1) in control subjects; the index was reduced in 
heart failure patients: in HFNEF, to 2.90 s-1 (95%CI, 2.56-3.24 s-1) and in HFREF, to 1.84 s-1 
(95%CI, 1.60-2.07 s-1).  This suggests that poor systolic function of LV is associated with 
lower dσ*/dtmax values. Therefore,  it can again be concluded that dσ*/dtmax is an appropriate 
index for representing assessment of LV contractile function in heart failure with/without 
preserved LV ejection fraction.  
 
 Controls (n=26) (n=21) HFNEF (n=26) HFREF (n=26) 
Age (years) 72  ±  8 70  ±  8 70  ±  8 
Gender (male:female) 16:10 16:10 16:10 
BSA (m2) 1.69  ±  0.20 1.71  ±  0.20 1.61  ±  0.20 
LVEF (%) 68.3  ±  5.1 66.5  ±  4.9 33  ±  13.7§* 
E/A ratio 0.96  ±  0.38 0.78  ±  0.24 1.26  ±  0.90* 
DT (ms) 214  ±  47 214  ±  67 157  ±  41§* 
HR (beats/min) 66  ±  10 72  ±  16 80  ±  11§ 
Septal E/E’ 8.48  ±  2.10 9.79  ±  3.29 13.68  ±  4.78§* 
Lateral E/E’ 6.64  ±  1.55 8.39  ±  2.76 10.28  ±  3.40§* 
dσ*/dtmax (s-1) 3.91  ±  0.87 2.90  ±  0.84§* 1.84  ±  0.59§* 
A, mitral atrial flow velocity on echo-Doppler; BSA, body surface area; DT, mitral E deceleration time; 
E, mitral early velocity; E’, septal mitral annular myocardial velocity on tissue Doppler imaging; HR, 
heart rate, LVEF, let ventricular ejection fraction.  
The values are expressed as mean  ±  SD. § and * denote statistically significant difference of HF 
compared to controls, HFREF compared to HFNEF patients, respectively (Bonferroni pairwise test, p 
value <0.05) 
Table 6. Patients characteristics and echocardiographic measurements in Group 1 (Controls), 
Group 2 (HFNEF) and Group 3 (HFREF). This table is related to our work in Ref [6]. 
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 Controls (95% CI) HFNEF (95% CI) HFREF (95% CI) 
dV/dtmax (ml/s)  353 (320, 385) 355 (329, 381) 233 (213, 252)§* 
Vpeak(cm/s) 106 (98, 115) 112 (104, 119) 73 (68, 78) §* 
LV mass (g) 147 (131, 164) 202 (183, 221)§ 213 (189, 297)§ 
dσ*/dtmax  (s-1) 3.91 (3.56, 4.26)  2.90 (2.56, 3.24)§* 1.84 (1.60, 2.07)§* 
§ and * denote statistically significant difference of HF compared to controls, HFREF compared to 
HFNEF patients, respectively 
Table 7. Comparison of the maximal flow rate dV/dtmax, Vpeak, LV mass, and dσ*/dtmax  in 
Group 1 (Controls), Group 2 (HFNEF) and Group 3 (HFREF). This table is related to our 
work in Ref [6]. 
6. Coronary Arterial Bypass Grafting (CABG) to salvage ischemic myocardial 
segments 
As is well known, coronary artery bypass graft (CABG) surgery has been the standard 
treatment for serious blockages in the coronary arteries and for re-perfusing myocardial 
ischemic segments to restore them to normal contractile state. During the surgery, one end 
of the graft is sewn to the aorta (or its subsidiary branches) to create proximal anastomosis, 
while the other end is attached to coronary artery below the area of blockage to create distal 
anastomosis. In this way, the oxygen-rich blood is taken directly from the aorta, bypasses 
the obstruction, and flows through the graft to perfuse and nourish the heart muscle. The 
most commonly used graft is the saphenous vein. Besides this vein graft, some arterial 
conduits (such as internal mammary artery, gastroepiploic artery and radial artery etc), and 
synthetic veins (such as Dacron, Teflon and Polytetrafluoroethylene-PTFE veins) are also 
suitable for CABG.  
Although the number of bypass operations keeps increasing, the CABG has not been 
without complications. Approximately 15% to 20% vein grafts occlude in the first year, and 
22.5% to 30% occlude within the first 2 years. At 10 years, approximately 60% of vein grafts 
are patent; only 50% of these vein grafts remain free of significant stenosis.  In order to 
intensively investigate the coronary arterial stenosis symptom, numerous research works 
have been carried out. One direction of these studies is to investigate the pathogenic 
mechanism of bypass graft failure. In this regard, vascular injury and biomechanical factors 
(such as wall shear stress related factors, compliance mismatch, etc.) are believed to 
stimulate cellular responses for pathological changes. In particular, hemodynamic flow 
patterns of CABG have considerable relevance to the causes and sites of pathogenesis. 
Hence, we have carried out simulation of hemodynamic flow patterns in CABG models, to 
look into the hemodynamic causes and mechanisms of lesions in coronary bypass grafts. 
The flow characteristics and hemodynamic parameters distributions in a complete CABG 
model (as shown in Figure 8) have been investigated computationally by us [15]. It is found 
that disturbed flow (flow separation and reattachment, vortical and secondary flows) 
patterns occur at both proximal and distal anastomoses, especially at the distal anastomosis. 
In addition, regions of high-OSI & low-WSS and low-OSI & high-WSS are found in the 
proximal and distal anastomoses, especially at the toe and heel regions of distal 
anastomosis. These regions are suspected to initiate the atherosclerotic lesions and are 
further worsened by the increasing permeability of low-density lipoprotein as indicated by 
high WSSG. The comparisons of segmental average of HPs (in the Table of Figure 8) further 
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imply that intimal hyperplasia is more prone to form in the distal anastomosis than the 
proximal anastomosis, especially along the suture line at the toe and heel of distal 
anastomosis, which was in line with the in-vivo observations.  
We then investigated the fluid dynamics of blood flow in two complete models of CABG for 
the right and left coronary artery separately, as shown in Figure 9 [16]. The results reveal that 
blood flow through the coronary artery bypass graft primarily occurs only during the diastolic 
phase of the cardiac cycle, which is in agreement with the physiological observation. However, 
at the onset of ejection, some backflow from the coronary artery into the bypass graft is found 
for the CABG to left coronary artery, which is absent for the right coronary artery. This 
reversal of flow during systole can be explained by the predominant intra-cardiac course of the 
left coronary artery system. As the same time, this study also found a low WSS region near the 
heel and a high WSS in the toe region of the anastomosis domain. 
 
 
(a) 
         
(b) 
Fig. 8. (a) The configuration to mimic complete CABG; (b) sketch maps of areas investigated 
for segmental averages of hemodynamic parameters (HPs) in proximal and distal 
anastomoses; 
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Name Labels in maps Area (mm2) <WSS> (Pa) <WSSG> <OSI> 
Proximal  
anastomosis 
heel A 4.23 4.48 11.88 0.41 
toe B 1.59 8.58 20.24 0.36 
part3 C 9.46 3.17 3.24 0.49 
part4 D 25.50 6.56 14.25 0.07 
suture_line E 12.00 5.06 9.01 0.29 
Distal  
anastomosis 
heel F 0.55 2.92 12.75 0.24 
toe G 0.55 28.04 147.17 0.02 
part3 H 9.70 14.63 64.24 0.07 
part4 I 6.81 0.85 3.59 0.22 
suture_line J 3.18 9.20 41.43 0.11 
(c) 
Fig. 8. (c) the segmental averages of HPs at these locations. This figure is adopted from our 
work in Ref 15 (Zhang et al., 2008). 
 
 
(a) 
 
(b) 
Fig. 9. Geometry (plane view) and dimensions (in mm) of the bypass models of: (a) The 
aorta-right coronary artery bypass model; (b) The aorta-left coronary artery bypass model 
(PSCA-Perfused Segment of the Coronary Artery; OSCA-Occluded Segment of the Coronary 
Artery; T-Toe; H-Heel). This figure is adopted from our work in Ref 16: (Sankaranarayanan 
et al., 2005). 
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CABG performance is based on flow characteristics at both the proximal and distal 
anastomoses.  So then, let us summarise the optimal geometrical parameters for proximal 
and distal anastomoses. For proximal anastomosis, a detailed study, on the effect of three 
grafting angles (viz. 45° forward facing, 45° backward facing, and 90°), has been carried out 
by Chua et al. [17]. The results show a flow separation region along the graft inner wall 
immediately after the heel at peak flow phase, which decreases in size with the grafting 
angle shifting from 45° forward facing to 45° backward facing. The existence of nearly fixed 
stagnating location, flow separation, vortex, high-WSS-low-OSI, low-WSS-high-OSI, and 
high WSSG is suspected to lead to graft stenosis. Among these three models, the 45° 
backward-facing graft is found to have the lowest variation range of time-averaged WSS 
and the lowest segmental average of WSSG, as shown in Figure 10; these parameters are 
then recommended  for  obtaining higher expected patency rates in bypass operations.  
 
 
Fig. 10. Contours of HPs: (a) time-averaged WSS; (b) time-averaged WSSG; and (c) OSI, on 
the surfaces of 45° forward-facing, 90°, and 45° backward-facing models (‘H’ means the 
region has high value, ‘L’ means the region has low values. This figure is adopted from our 
work in Ref 17 (Chua et al., 2005b). 
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At the distal anastomosis junction of CABG, the important geometrical parameters for 
smooth flow are the angle (α) and the diameter ratio (φ) between the graft and host artery. 
The hemodynamics  associated with these parametric  were investigated by Xiong and 
Chong [18], over a  range of φ (1:1, 1.5:1 and 2:1) and α (15°, 30°, 45° and 60°) in 
physiological coronary flow conditions. It is found that increasing φ from 1:1 to 1.5:1 almost 
eliminates both low WSS and high OSI at the toe. However, further increasing φ to 2:1 
causes elevated OSI for most of the host artery segment in the anastomotic region and in 
almost the entire graft. On the other hand, varying α is also found to change certain aspects 
of hemodynamics, although less than those changes related with different values of φ. A 
smaller value of α is found to be associated with a higher OSI in the anastomotic region, 
whereas a larger α causes higher WSSG on the artery floor. Therefore, it is suggested that for 
distal coronary anastomosis (with a 20:80 proximal to distal flow division ratio maintained 
in the host artery), the geometry associated with φ = 1.5 and α = 30–45° is favorable for 
enhancing long-term performance.  
7. Surgical Ventricular Restoration (SVR), combined with CABG, restores LV 
shape and improves cardiac contractility  
7.1 Introduction 
Ischemic heart disease is one of the most widely spread, progressive and prognostically 
unfavorable diseases of the cardiovascular system.  In ischemic dilated cardiomyopathy 
(IDC) patients, the remodeling process involves a lesser systolic LV curved shape, increase 
of peak wall stress, and decrease of contractile functional index, compared with normal 
subjects.  Surgical ventricular restoration (SVR) is performed in chronic ischemic heart 
disease patients with large non-aneurysmal or aneurysmal post-myocardial infarction 
zones. It involves operative methods, that reduce LV volume and ‘restore’ ventricular 
ellipsoidal shape, by exclusion of anteroseptal, apical, and anterolateral LV scarred 
segments by means of intra-cardiac patch or direct closure.   
For patients in heart failure (HF) resulting from serious myocardial diseases of ischemic 
dilated cardiomyopathy and myocardial infarction (MI), surgical ventricular restoration 
(SVR), designed to restore the LV to its normal shape (reversal of LV remodeling), is 
performed usually in conjunction with coronary artery bypass grafting (CABG). In our 
study [19], in 40 ischemic dilated cardiomyopathy (IDC) patients who underwent SVR and 
CABG, there was found to be: (i) decrease in end-diastolic volume from 318 ± 63 ml to 206 ± 
59 ml (p<0.01) and in end-systolic volume from 228 ± 58 ml to 133 ± 61 ml (p<0.01), (ii) 
increase in LV ejection fraction from 26 ± 7% to 31 ± 8% (p<0.01), (iii) decrease in LV mass 
(from 204 ± 49 g to 187 ± 53 g, p<0.01), (iv) decrease in peak normalized wall stress (PNWS) 
(from 4.30 ± 0.95 to 3.31 ± 0.75, p<0.01) , (v) increase in end-systolic sphericity index SI (from 
0.57 ± 0.094 to 0.67 ± 0.13, p<0.01), (vi) increased value of shape (S) index (from 0.44  ±  0.085 
to 0.54  ±  0.089, p<0.01) during end-systole indicating that LV became more spherical after 
SVR, and most importantly (vii) improvement in LV contractility index dσ*/dtmax (from 2.69 
 ±  0.74 s-1 to 3.23  ±  0.73 s-1, p<0.01).  
Thus, in IDC patients, surgical ventricular restoration (in combination with CABG) aiming 
to reverse LV remodeling, has shown to (i) improve ventricular function and decrease wall 
stress, along with making a more curved apex, and (ii) improve cardiac contractility.  It is 
not the LV shape alone that defines LV contractility. Rather, a complex interaction of the rate 
of change of shape factor (dS/dtmax) along with LV maximal flow rate and LV mass may 
explain the improvement in LV contractility.  
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7.2 Clinical study 
The study was carried to retrospectively evaluate (with cardiac MRI) the changes on systolic 
function and LV wall stress, the relationships between LV geometry (shape) and dimensions 
and systolic function after SVR performed in chronic ischemic heart disease patients with 
aneurismal postmyocardial infarction zones. The study consisted of 40 patients with 
ischemic dilated cardiomyopathy who had SVR; the age of the patients averaged 69 years 
(range, 52-84 years). MRI scans were performed 2 weeks before surgery (pre-surgery) and 1 
week after the surgery; the details of the MRI procedure are reported in our earlier work 
[19].  
Cardiac magnetic resonance imaging (MRI) provides the means to study heart structure and 
function: the ventricular systolic and diastolic volumes (and hence ejection fraction) are 
easily assessed reproducibly and accurately; the regional wall motion of the asynergy area 
and the remote myocardium can be measured by several quantitative means, including with 
myocardial tagging; the presence or absence of nonviable, irreversible scar can be detected 
with gadolinium-based interstitial contrast agents.  
Data Analysis, 3-dimensional modeling of LV:  For analysis, the images were displayed on 
a computer monitor in a cine-loop mode using CMRtools, to reconstruct the 3-dimensional 
model of the left ventricle (LV).  The LV epicardial and endocardial borders were outlined, 
and all the frames were delineated to produce a volume curve from end-diastolic and end-
systolic phases.  These measurements were used to determine the end-diastolic volume 
(EDV), end-systolic volume (ESV), stroke volume (SV), ejection fraction (EF), and LV mass.  
Ellipsoidal Shape factor, Eccentricity (E) and sphericity index and normalized wall stress: The LV is 
modeled as a prolate spheroid, truncated 50% of the distance from equator to base, as 
shown in figure 11 [20, 21].  Then, the left ventricular cavity wall volume is calculated, from 
the endocardial anterior-posterior (AP) and base-apex (BA) lengths [20], as: 
 
2 2
9
8 1.5 2 1.5 2
m
BA AP BA AP
V h h
⎡ ⎤⎛ ⎞⎛ ⎞ ⎛ ⎞⎛ ⎞⎢ ⎥= + + −⎜ ⎟⎜ ⎟ ⎜ ⎟⎜ ⎟⎢ ⎥⎝ ⎠⎝ ⎠ ⎝ ⎠⎝ ⎠⎣ ⎦
 (9) 
wherein the BA and AP dimensions are identified in figure 12.   The mean wall thickness (h) 
is calculated at each cavity volume, from the above equation, by assuming that myocardial 
wall volume (Vm ) remains constant throughout the cardiac cycle.  The endocardial minor 
axis dimension (SA) and major axis dimension (LA), shape factor (S), eccentricity (E) and 
sphericity index (SI) were then calculated as follows (refer figures 11 and 12): 
 
0.5
2 2
2
SA AP / 2;  LA BA /1.5,  S SA /LA,   ,   SI AP /BP
BA AP
E
BA
⎛ ⎞
−
= = = = =⎜ ⎟⎜ ⎟⎝ ⎠
 (10) 
wherein BA (the LV long axis) is defined as the longest distance from the apex to the base of 
the LV (defined as the mitral annular plane), as measured on the four-chamber cine MRI 
view of the heart; AP is defined as the widest LV minor axis (Figure 12).  A small value of SI 
implies an ellipsoid LV, whereas values approaching “1” suggest a more spherical LV. The 
SI at end-diastole (SIed) and end-systole (SIes), the % shortening of the long and minor axes, 
as well as the difference between end-diastolic and end-systolic values of SI, (SIed - SIes) were 
calculated and are tabulated in Table 10 below. 
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The time-varying circumferential normalized wall stress, NWS(t), is calculated from the 
instantaneous measurements of LV dimensions and wall thickness, by treating the LV as a 
prolate spheroid model truncated 50% of the distance from equator to base [20, 21] 
 
( )29 ( )
( ) 32 ( )
( ) 1
( )2 ( ) 1
( )
AP t
SI
AP t h t
NWS t
AP th t
h t
⎡ ⎤⎢ ⎥⎢ ⎥= −⎢ ⎥+⎢ ⎥⎣ ⎦
 (11) 
The LV wall thickness, h(t), is calculated from the following formula (based on the above 
equation 9), by assuming that the myocardial wall volume (Vm) remains constant 
throughout the cardiac cycle:  
 
( ) ( ) ( ) ( ) ( )
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BA t AP t BA t AP t
h t h t V t
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 (12) 
 
                                                   
Fig. 11. LV model geometry, showing the major and minor radii of the inner surface of the 
LV (LA & SA) and the wall-thickness (h). 
Cardicac Contractility dσ*/dtmax:  In order to compute the contractility index by employing 
the above equation (8), a 6-order polynomial function to curve-fit the volumes-time data to 
calculate the volume rate (dV/dt) by differentiating it. Then the contractility index dσ*/dtmax is 
calculated as: 
         
( )
max
/ 3
* /
2 m maxmax
d P dV
d dt
dt V dt
θσσ
⎛ ⎞
= = ⎜ ⎟⎝ ⎠                 
whereVm is myocardial volume at the end-diastolic phase.   
www.intechopen.com
Cardiac Myocardial Disease States (Such as Myocardial Infarction) Cause Left Ventricular  
Remodeling with Decreased Contractility and Lead to Heart Failure; Interventions by Coronary … 
 
807 
 
 
(a) Pre-SVR 
 
 
(b) Post-SVR 
 
Fig. 12. Short-axis (panels A and C) and long-axis (panels B and D) magnetic resonance 
images of patients, before (panels A and B) and after (panels C and D) surgical ventricular 
restoration (SVR). Multiple short-axis cines from the apex to the base of the heart  
(or orientated axial) and long-axis cines are used to quantify LV function. Anterior-posterior 
(AP) (panels A and C) and base-apex (BA) (panels B and D) were measured from 2-D CMR 
imaging before (panels A and B) and after (panels C and D) SVR during cardiac cycle. The 
shape factor S, eccentricity index and sphericity index (SI) were calculated from Equation 
(6). It can be noted that the long-axis decreased more dramatically compared with the short-
axis dimension, thereby producing a more spherical ventricle. This figure is adopted from 
our work presented in Ref 19. 
 (A) (B)
BA 
AP
 (D) (C) 
BA
AP
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7.3 Clinical results  
All 40 patients were treated with CABG and SVR (endoventricular circular patch plasty). 
The age of the patients averaged 69 years (range, 52-84 years). Among them, 19 patients had 
severe mitral regurgitation and received additional MVS. 28 patients had CHF.  The baseline 
patient characteristics are summarized in Table 8.  
 
Variables Value 
Male : female 36:4 
Age (years) 69  ±  9 
Body surface area (m2) 1.98  ±  0.18 
Coronary artery disease  39 (98%) 
Hypertension 19 (48%) 
Diabetes mellitus 13 (33%) 
Tobacco 23 (58%) 
Congestive heart failure 28 (70%) 
Peripheral arterial disease 3 (8%) 
Stroke 2 (5%) 
Creatinine (mg/dL) 1.17  ±  0.29 
Prior cardiac surgery 19 (48%) 
New York Heart Association class  
   I-II 26 (65%) 
   III-IV 14 (35%) 
Surgery  
Surgical ventricular restoration + coronary artery bypass 
grafting  
21 (52%) 
Surgical ventricular restoration + coronary artery bypass 
grafting + mitral valve surgery 
19 (48%) 
Values are mean  ±  SD or numbers of patients (percentages). 
Table 8. Patients’ characteristics and clinical data (n=40). This table is related to our work in 
Ref [19]. 
7.4 Left ventricular functional indexes changes pre and post-surgery (MRI parameters) 
Figure 12 shows typical short-axis and long-axis magnetic resonance images of patient pre- 
and post-SVR and how to calculate shape, eccentricity and sphericity index. It is noted that 
the long-axis decreased more dramatically compared with short-axis dimension, thereby 
producing a more spherical LV. Figure 13 shows typical 3-dimensional modeling of LV from 
CMR images using LVtools pre and post SVR.    
The intraobserver and interobserver data for EDV, ESV and mass for pre- and post-surgery 
groups are shown in Table 9.  Table 10 summarizes the mean LV functional indexes pre and 
post-SVR. Following SVR, there was a significant decrease in the dimensions of both the 
long- and short-axes of the LV. However, the long-axis dimension of the LV decreased more 
than the short-axis dimension, resulting in a more spherical ventricle post-SVR. There was a 
significantly reduction in end-diastolic volume index (EDVI), end-systolic volume index 
(ESVI), LV stroke volume index (SVI), LV mass index, and peak normalized wall stress after 
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SVR (Table 3). The values of LV EDVI, ESVI, LVEF and the contractility index dσ*/dtmax pre- 
and post-SVR are also shown in the scatter plots of Figure 14.  
Table 10 provides the sphericity index (SI) values in end-diastole and end-systole and its 
diastolic-systolic change, as well as the % shortening of the long- and short-axes. During a 
cardiac cycle, LV shape becomes less spherical in systole (SI smaller) than in diastole (SI closer 
to ‘1’). The diastolic-systolic change in SI (SIed-SIes) is significantly augmented by the operation, 
despite the LV chamber becoming more spherical. The % shortening of long-axis is not 
significantly altered, but the % shortening of the short-axis is significantly increased by the 
operation. Despite the seemingly unfavorable spherical LV shape post-SVR, the LV contractile 
function is significantly improved, as indicated by the increased value of dσ*/dtmax. 
The scatter plots of figure 14 graphically illustrate pre- and post-SVR values of ventricular 
end-diastolic volume, end-systolic volume, LVEF and contractility index dσ*/dtmax. From 
Tables 9 and 10, we can note a significant reduction in end-diastolic volume (318 ± 63 ml vs. 
206 ± 59 ml, p<0.01), end-systolic volume (228 ± 58 ml vs. 133 ± 61 ml, p<0.01), LV mass (204 
± 49 g vs. 187 ± 53 g, p<0.01), and peak normalized wall stress (PNWS) (4.64 ± 0.98 vs. 3.72 ± 
0.87, p<0.01). Increased sphericity index SI (0.57 ± 0.094 vs. 0.67 ± 0.13, p<0.01) and increased 
shape factor (S) (0.44 ± 0.085 vs. 0.54 ± 0.089, p<0.01) during end-systole indicates that the 
LV became more spherical after SVR.   
 
 
Pre-SVR Post-SVR 
End 
diastolic 
volume  
(ml) 
End 
systolic 
volume 
(ml) 
LV mass 
(g) 
End 
diastolic 
volume 
(ml) 
End systolic 
volume 
(ml) 
LV mass 
(g) 
Intraobserver       
Mean 318 ±  63 228 ±  58 204 ±  49 206 ±  59 133 ±  61 187  ±  53 
Mean 
difference 
1.1  ±  8.60 
-1.4 ±  
8.38 
-5.1  ±  7.96 0.3  ±  6.94 -1.5  ±  3.20 0.6  ±  8.51 
Correlation 
coefficient 
0.99 0.99 0.99 0.99 0.99 0.99 
t-test p N.S. N.S. N.S. N.S. N.S. N.S. 
% variability 1.50  ±  1.99 
2.13 ±  
2.45 
3.74  ±  3.71 
2.42 ±  
2.32 
1.79  ±  1.77 4.09  ±  3.02 
Interobserver       
Mean  318 ±  65 231 ±  61 206 ±  52 207 ±  60 135 ±  62 189  ±  51 
Mean 
difference  
0.3  ±  10 7.9  ±  10 7.6  ±  14 2.0  ±  8.9 5.5  ±  10 3.1  ±  9.8 
Correlation 
coefficient 
0.99 0.99 0.97 0.99 0.99 0.98 
t-test p N.S. N.S. N.S. N.S. N.S. N.S. 
% variability  2.73  ±  1.58 
4.11 
 ±  2.93 5.90  ±  3.13 
3.44 
 ±  2.94 5.87  ±  6.23 4.81  ±  2.49 
N.S., not significant. 
Data are mean  ±  SD. 
Table 9. Reproducibility data in patients pre- and post-SVR. This table is related to our work 
in Ref [19]. 
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The prime effect of SVR may be viewed as:  (i) effecting a decrease in myocardial oxygen 
consumption by reduction of LV peak normalized wall stress, resulting in improved 
functioning of LV, and (ii) augmentation of value of the contractility index  dσ*/dtmax (2.69 ± 
0.74 s-1 vs. 3.23 ± 0.73 s-1, p<0.01). This improvement may be attributed to (i) increased 
maximal flow dV/dtmax with reduced LV mass, and (ii) improved regional contraction and 
contractility of the remote myocardium. The improvement in remote myocardial 
performance is likely due to reduced myocardial stress, along with effective and complete 
revascularization. This is because the SVR procedure reduces the volume by more 
dramatically reducing long-axis dimension compared with the short-axis dimension, and 
producing a more spherical ventricle. 
Based on Table 10, increased LV contractile function dσ*/dtmax can be not only associated with 
increased maximal flow dV/dtmax, reduced LV mass, and also increased maximal change rate of 
shape factor dS/dtmax (r=0.414, p<0.001).  There was also good correlation between dσ*/dtmax and 
LVEF (r=0.69, p<0.001, pre-SVR; r=0.77, p<0.001, post-SVR) (Figure 15).  
 
Variables Pre SVR (n=40) Post SVR (n=40) 
Cardiac index (L/min/m2) 2.84  ±  0.74 2.59  ±  0.74 
Mean arterial pressure (mmHg) 85  ±  14        84  ±  8 
Systolic blood pressure (mmHg)        115  ±  20      113  ±  10 
Diastolic blood pressure (mmHg) 71  ±  12        70  ±  8 
End diastolic volume index (ml/m2)        156  ±  39      110  ±  33* 
End systolic volume index (ml/ m2)        117  ±  39  77  ±  31* 
Stroke volume index (ml/ m2)          39  ±  9        33  ±  8* 
Left ventricular ejection fraction (%)          26  ±  7        31  ±  10* 
LV mass index (g/m2)        112  ±  25      101  ±  23* 
End-diastolic long axis, BAed(cm)     10.89  ±  1.16     8.31  ±  1.00* 
End-diastolic short axis, APed(cm)       7.00  ±  0.80  6.64  ±  0.78* 
End-systolic long axis, BAes(cm)     10.37  ±  1.20  7.87  ±  1.05* 
End-systolic short axis, APes (cm)       5.86  ±  0.98  5.23  ±  1.06* 
End-diastolic sphericity Index, SIed  0.65  ±  0.087     0.81  ±  0.11* 
End-systolic sphericity index, SIes  0.57  ±  0.094  0.67  ±  0.13* 
Difference between end-diastolic and  
end-systolic sphericity index, SIed - SIes 
0.077  ±  0.043   0.14  ±  0.059* 
Long axis shortening (%) 4.8  ±  3.6      5.4  ±  4.4 
Short axis shortening (%)       16.4  ±  6.8       22  ±  9.7* 
dV/dtmax (ml/s)        364  ±  83     401  ±  81* 
Pressure normalized wall stress 4.30  ±  0.95 3.31  ±  0.75* 
Stroke work (mmHg·L) 6.61  ±  1.96    5.46  ±  1.64* 
dσ*/dtmax (s-1) 2.69  ±  0.74 3.23  ±  0.73* 
 
*p < 0.05.  
Values are mean  ±  SD. 
 
Table 10. Patients’ data pre- and post-SVR. This table is related to our work in Ref [19]. 
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(a)Pre-SVR ED & ES 
 
 
(b) Post-SVR ED & ES 
 
Fig. 13. 3-dimensional reconstructions during end-diastole (panels A and C) and end-systole 
(panels B and D) phases before (panels A and B) and after (panels C and D) SVR using 
LVtools. It is created from the endocardial and epicardial contours, which were drawn for 
calculations of ventricular volumes and function from the multiple short-axis cines (Figure 
12). This figure is based on our work presented in Ref. 19. 
(B) (A) 
(D) (C) 
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Fig. 14. Changes in end-diastolic volume (EDV), end-systolic volume (ESV), LVEF and 
contractility index dσ*/dtmax after SVR.  This figure is adopted from our work in Ref. 19. 
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Fig. 15. Association between dσ*/dtmax and left ventricular (LV) ejection fraction (EF) pre- and 
post-SVR. (Solid line: dσ*/dtmax=9.045×EF+1.091, r=0.69, p<0.001 for pre-SVR; dash line: 
dσ*/dtmax=9.969×EF+1.337, r=0.77, p<0.001 for post-SVR).  This figure is adopted from our 
work in Ref 19.  
8. Conclusion 
Myocardial infarct patients’ hearts undergo substantial remodeling and loss of contractility, 
and can progress to heart failure. Echocardiographic texture analysis enables us to 
determine the percentage volume of the infarcted segments in the ventricular volume.   
The ventricular remodelling is defined in terms of reduced alteration in curvedness index 
(%∆C) from end-diastole to end-systole.  The cardiac contractility is assessed in terms of the 
value of the index dσ*/dtmax.  
With the help of these three indices of percentage volume of MI segments, curvedness index 
and contractility index, we can track and assess LV progression to heart failure, and its 
recovery following CABG and SVR.    
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